Get the Stockscreener App
3.82
0.53%
0.02
After Hours:
3.81
-0.010
-0.26%
Xbiotech Inc stock is traded at $3.82, with a volume of 38,210.
It is up +0.53% in the last 24 hours and down -43.32% over the past month.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
See More
Previous Close:
$3.80
Open:
$3.84
24h Volume:
38,210
Relative Volume:
0.59
Market Cap:
$116.45M
Revenue:
$4.01M
Net Income/Loss:
$-35.01M
P/E Ratio:
-3.2931
EPS:
-1.16
Net Cash Flow:
$-24.53M
1W Performance:
-1.55%
1M Performance:
-43.32%
6M Performance:
-41.95%
1Y Performance:
-21.56%
1-Day Range:
$3.80
$3.99
1-Week Range:
$3.64
$4.03
52-Week Range:
$3.51
$9.96
Xbiotech Inc Stock (XBIT) Company Profile
Name
Xbiotech Inc
Sector
Industry
Phone
512-386-2900
Address
5217 WINNEBAGO LANE, AUSTIN, TX
Compare XBIT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
3.82 | 116.45M | 4.01M | -35.01M | -24.53M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-14-19 | Initiated | Piper Jaffray | Overweight |
| Apr-21-17 | Downgrade | Noble Financial | Buy → Hold |
| Jun-28-16 | Reiterated | Noble Financial | Buy |
Xbiotech Inc Stock (XBIT) Latest News
XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm - Kilgore News Herald
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Stockholders to Reach Out - Markets Insider
Jane Street Group LLC Acquires Shares of 11,141 XBiotech Inc. (NASDAQ:XBIT) - Defense World
Wolf Haldenstein Adler Freeman & Herz LLP announces that it - GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities laws - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Stockholders to Connect - AccessWire
XBiotech Inc.'s (NASDAQ:XBIT) largest shareholders are individual investors with 49% ownership, insiders own 35% - Yahoo Finance
Geode Capital Management LLC Acquires 22,059 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
Barclays PLC Acquires 18,761 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc.VKTX - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Walmart Inc.WMT - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire
State Street Corp Grows Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech Inc. Appoints Dr. Tak W. Mak to its Board of Directors - Defense World
XBiotech Appoints Renowned Scientist to Board of Directors - TipRanks
Franklin Resources Inc. Trims Stock Holdings in JD.com, Inc. (NASDAQ:JD) - Defense World
XBiotech (NASDAQ:XBIT) Has Debt But No Earnings; Should You Worry? - Simply Wall St
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc.SANA - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kzKSPI - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesCRBU - PR Newswire
XBiotech halts all rheumatology research after missing Phase II endpoints - Yahoo Finance
Stock market news: YSX Tech. -28.67%, XBiotech -24.76% among biggest losers during mid day trading - Business Upturn
Another bump in the road for XBiotech and bermekimab - The Pharma Letter
Xbiotech Shares Hit 52-Week Low on Halted Rheumatology Program - MarketWatch
XBiotech Stock Hits 52-Week Low at $3.75 Amid Market Fluctuations - Investing.com
Stock market today: XBiotech -31.66%, Nvni Group -31.59% among biggest losers in early trading - Business Upturn
XBiotech trading resumes - Nasdaq
XBiotech Halts Rheumatology Clinical Program - MarketWatch
XBiotech Pauses Rheumatology program - GlobeNewswire
XBiotech Halts Rheumatology Program After Major Data Irregularities Found in Phase 2 Trial - StockTitan
Fmr LLC Has $224,000 Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech Inc. (NASDAQ:XBIT) Stock Position Lifted by Charles Schwab Investment Management Inc. - Defense World
(XBIT) Proactive Strategies - Stock Traders Daily
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
12,157 Shares in XBiotech Inc. (NASDAQ:XBIT) Purchased by MetLife Investment Management LLC - Defense World
XBiotech (NASDAQ:XBIT) vs. Ironwood Pharmaceuticals (NASDAQ:IRWD) Critical Analysis - Defense World
(XBIT) Investment Analysis and Advice - Stock Traders Daily
Connor Clark & Lunn Investment Management Ltd. Has $585,000 Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
Trend Tracker for (XBIT) - Stock Traders Daily
Empowered Funds LLC Cuts Stock Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat
Cancer Cachexia Market Demand, Segments, And Growth to 2033 Helsinn, Aphios, Eli Lilly, XBiotech - openPR
How To Trade (XBIT) - Stock Traders Daily
XBiotech: Q3 Earnings Snapshot - New Haven Register
Transforming lives for those battling cancer with the speed & precision of AIRakovina Therapeutics (TSXV: RKV) | GCFF - NAI 500
XBiotech (NASDAQ:XBIT) Stock Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat
XBiotech Inc.'s (NASDAQ:XBIT) 12% gain last week benefited both individual investors who own 49% as well as insiders - Simply Wall St
(XBIT) Technical Data - Stock Traders Daily
XBiotech (NASDAQ:XBIT) Share Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Xbiotech Inc Stock (XBIT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
4.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):